Evaluation of characteristics of sarcopenia by the formula of Ishii in the type 2 diabetes mellitus

  • Vu Minh Phuc National Hospital of Endocrinology
  • Nguyễn Thị Phi Nga Học viện Quân Y
  • Phạm Thúy Hường Bệnh viện Quân y 103

Main Article Content

Keywords

Sarcopenia, type 2 diabetes millitus, formula of Ishii

Abstract

Objective: To evaluate of characteristics of sarcopenia by the formula of Ishii in the type 2 diabetes mellitus. Subject and method: A cross-sectional study on 479 patients type 2 diabetes mellitus admitted at the National Hospital of Endocrinology and the 103 Military Hospital from January 2022 to May 2022. Result: The average age of the research group was là 66.56 ± 8.84 (males: 66.70 ± 9.31, females: 66.44 ± 8.38); The average handgrip strengh was 27.67 ± 8.48kg (males: 33.11 ± 8.01, females: 22.55 ± 5.03); The average calf circumference was 33.84 ± 2.92cm (males: 34.54 ± 2.79, females: 33.18 ± 2.89). The prevalence of sarcopenia was 22.8% (males: 29.3% and females: 16.6%); in group < 60 ages: 6.9%, ≥ 60 ages: 27.8%; in group > 10 years: 28.6%, ≤ 10 years: 17.0%; in group hypertension: 26.9%, nonhypertension: 17.5%; in group BMI ≤ 22.5: 31.1%, BMI > 22.5: 17.3%; in group eGFR < 60ml/min/1.73m2: 39.3%, ≥ 60ml/min/1.73m2: 7.6%. Conclusion: The prevalence of sarcopenia was 22.8% (males: 29.3% and females: 16.6%). It related to age, duration of diabetes, eGFR, hypertension, BMI; not related to  blood glucose, HbA1c, living area and educational status.

Article Details

References

1. Bộ Y tế (2020) Hướng dẫn chẩn đoán và điều trị đái tháo đường típ 2. Bộ Y tế. Retrieved from https://luatvietnam.vn/y-te/quyet-dinh-5481-qd-byt-huong-dan-chan-doan-va-dieu-tri-dai-thao-duong-tip-2-196326-d1.html.
2. Nguyễn Ngọc Tâm, Vũ Thị Thanh Huyền, Phạm Thắng, (2021) Nghiên cứu áp dụng một số phương pháp sàng lọc sarcopenia ở người bệnh cao tuổi. Đại học Y Hà Nội. Retrieved from http://dulieuso. hmu.edu.vn/handle/hmu/2060.
3. Nguyễn Thị Thúy Hằng (2021) Nghiên cứu tình trạng mất cơ ở bệnh nhân đái tháo đường typ 2 và bước đầu đánh giá hiệu quả bằng luyện tập. Đại học Y Hà Nội, Retrieved from http://dulieuso. hmu.edu.vn//handle/hmu/2089.
4. Wang T, Feng X, Zhou J, Gong H, Xia S, Wei Q, Yu L, (2016) Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Scientific Reports 6: 1-7. https://doi.org/10.1038/srep38937.
5. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima, K, Arai H (2020) Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. Journal of the American Medical Directors Association 21(3): 300-307.. https://doi.org/10.1016/j.jamda.2019.12.012.
6. World Health Organization (2000) The Asia - Pacific perspective: Redefining obesity and its treatment. Retrieved from http://apps.who.int/bookorders.
7. Ishii S, Tanaka T, Shibasaki, K, Ouchi Y, Kikutani T, Higashiguchi T, Iijima K (2014) Development of a simple screening test for sarcopenia in older adults. Geriatrics and Gerontology International 14(1): 93-101. https://doi.org/10.1111/ggi.12197.
8. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1): 31-41. https://doi.org/10.1159/ 000180580.
9. American Medical Association (2001) Executive summary of the third report (NCEP) -adult treatment panel III. Journal of American Medical Association 285(19): 2486-2497.
10. Sazlina SG, Lee PY, Chan YM, Hamid AMS, Tan NC, (2020) The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia. Plos One 15(5): 0233299. https://doi.org/10.1371/journal.pone.0233299.
11. Izzo A, Massimino E, Riccardi G, Pepa G Della (2021) A narrative review on sarcopenia in type 2 diabetes mellitus: Prevalence and associated factors. https://doi.org/10.3390/nu13010183.
12. Sugimoto K, Tabara Y, Ikegami H, Takata Y, Kamide K, Ikezoe T, Rakugi H (2019) Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus. Journal of Diabetes Investigation, 10(6): 1471-1479. https://doi.org/ 10.1111/jdi.13070.
13. Fung FY, Koh YLE, Malhotra R, Ostbye T, Lee PY, Shariff Ghazali S, Tan NC (2019) Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting. BMC Geriatrics 19(1). https://doi.org/10.1186/s12877-019-1137-8.
14. De Souza VA, Oliveira D, Barbosa SR, Corrêa JODA, Colugnati FAB, Mansur HN, Bastos MG (2017) Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors. PLoS ONE 12(4): 1-13. https://doi.org/10.1371/journal.pone.0176230.